Search Results - "Anosova, Natalie G"
-
1
Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates
Published in Nature communications (10-03-2023)“…The rapid spread of the SARS-CoV-2 Omicron subvariants, despite the implementation of booster vaccination, has raised questions about the durability of…”
Get full text
Journal Article -
2
Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates
Published in Nature communications (31-03-2022)“…The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that partly evade neutralizing antibodies raises concerns of reduced…”
Get full text
Journal Article -
3
Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza
Published in npj vaccines (16-12-2021)“…Recent approval of mRNA vaccines for emergency use against COVID-19 is likely to promote rapid development of mRNA-based vaccines targeting a wide range of…”
Get full text
Journal Article -
4
Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters
Published in Communications medicine (26-05-2023)“…Background Since the beginning of the COVID-19 pandemic, several variants of concern (VOC) have emerged for which there is evidence of an increase in…”
Get full text
Journal Article -
5
Immunological Distinctions between Acellular and Whole-Cell Pertussis Immunizations of Baboons Persist for at Least One Year after Acellular Vaccine Boosting
Published in Vaccines (Basel) (02-12-2020)“…While both whole-cell (wP) and acellular pertussis (aP) vaccines have been highly effective at reducing the global pertussis disease burden, there are concerns…”
Get full text
Journal Article -
6
Novel structural insights for a pair of monoclonal antibodies recognizing non-overlapping epitopes of the glucosyltransferase domain of Clostridium difficile toxin B
Published in Current research in structural biology (01-01-2022)“…Clostridium difficile toxins are the primary causative agents for hospital-acquired diarrhea and pseudomembranous colitis. Numerous monoclonal antibodies…”
Get full text
Journal Article -
7
Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity model
Published in Vaccine (23-02-2022)“…•No breadth against VoC attained with heterologous sequences in primary vaccination.•Boosting with original vaccine results in breadth against VoC and…”
Get full text
Journal Article -
8
Deciphering the domain specificity of C. difficile toxin neutralizing antibodies
Published in Vaccine (27-06-2019)“…Clostridium difficile infection (CDI) is the principal cause of nosocomial diarrhea and pseudomembranous colitis associated with antibiotic therapy. The…”
Get full text
Journal Article -
9
Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models
Published in npj vaccines (19-04-2021)“…Emergency use authorization of COVID vaccines has brought hope to mitigate pandemic of coronavirus disease 2019 (COVID-19). However, there remains a need for…”
Get full text
Journal Article -
10
Proteomic profiling of precipitated Clostridioides difficile toxin A and B antibodies
Published in Vaccine (18-02-2020)“…•Anti-toxin A and B Igs purified from sera after C. difficile infection or vaccination.•Proteomes of secreted anti-toxin Igs analysed by mass spectrometric…”
Get full text
Journal Article -
11
Limitations of Murine Models for Assessment of Antibody-Mediated Therapies or Vaccine Candidates against Staphylococcus epidermidis Bloodstream Infection
Published in Infection and immunity (01-04-2016)“…Staphylococcus epidermidis is normally a commensal colonizer of human skin and mucus membranes, but, due to its ability to form biofilms on indwelling medical…”
Get full text
Journal Article -
12
Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters
Published in Journal of medical microbiology (01-09-2013)“…Clostridium difficile infection (CDI) has been identified as the leading cause of nosocomial diarrhoea and pseudomembranous colitis associated with antibiotic…”
Get full text
Journal Article -
13
A Combination of Three Fully Human Toxin A- and Toxin B-Specific Monoclonal Antibodies Protects against Challenge with Highly Virulent Epidemic Strains of Clostridium difficile in the Hamster Model
Published in Clinical and vaccine immunology (01-07-2015)“…Clostridium difficile infection (CDI) is the principal cause of nosocomial diarrhea and pseudomembranous colitis associated with antibiotic therapy. Recent…”
Get full text
Journal Article -
14
CD28-independent Costimulation of T Cells in Alloimmune Responses
Published in The Journal of immunology (1950) (01-07-2001)“…T cell costimulation by B7 molecules plays an important role in the regulation of alloimmune responses. Although both B7-1 and B7-2 bind CD28 and CTLA-4 on T…”
Get full text
Journal Article -
15
CD4+ T Cell Responses to Self- and Mutated p53 Determinants During Tumorigenesis in Mice
Published in The Journal of immunology (1950) (01-06-2000)“…We analyzed CD4+ T helper responses to wild-type (wt) and mutated (mut) p53 protein in normal and tumor-bearing mice. In normal mice, we observed that although…”
Get full text
Journal Article -
16
Induction of T-cell response to cryptic MHC determinants during allograft rejection
Published in Human immunology (01-12-2000)“…The presentation of MHC peptides by recipient and donor antigen presenting cells is an essential element in allorecognition and allograft rejection. MHC…”
Get full text
Journal Article -
17
Increasing Domain Coverage Improves Neutralizing Potency of C. difficile Toxin-specific Antibodies
Published in The Journal of immunology (1950) (01-05-2018)“…Clostridiumdifficile (C.difficile)is a significant human pathogen. C.difficile infection (CDI) causesclinical symptoms ranging from diarrhea to…”
Get full text
Journal Article -
18
-
19
IMMUNE MECHANISMS INVOLVED IN REJECTION OF RETINAL ALLOGRAFTS IN MICE: Abstract# 532 Poster Board #-Session: P171-II
Published in Transplantation (01-04-2000)Get full text
Journal Article -
20
Antigenicity and immunogenicity of allogeneic retinal transplants
Published in The Journal of clinical investigation (15-10-2001)“…The transplantation of neuronal cells and tissues represents a promising approach for the treatment of incurable neurodegenerative diseases. Indeed, it has…”
Get full text
Journal Article